ArticleInternational journal of clinical oncology2023

Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer.

Yoshitaka Saito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.